- Home
- Publications
- Publication Search
- Publication Details
Title
Plazomicin: A Next-Generation Aminoglycoside
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-12-04
DOI
10.1002/phar.2203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration
- (2018) Tomefa E. Asempa et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?
- (2018) Nicholas S. Britt et al. AMERICAN JOURNAL OF INFECTION CONTROL
- A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
- (2018) Lynn E. Connolly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Efficacy of Plazomicin Alone or in Combination with Meropenem or Tigecycline against Enterobacteriaceae Isolates Exhibiting Various Resistance Mechanisms in an Immunocompetent Murine Septicemia Model
- (2018) Kamilia Abdelraouf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii
- (2018) Nattawat Teerawattanapong et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)
- (2017) Yunliang Zhang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates
- (2017) Valérie Denervaud-Tendon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections
- (2016) Joshua T. Thaden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Statistical Approaches to Composite Endpoints ∗
- (2016) William S. Weintraub JACC-Cardiovascular Interventions
- Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
- (2015) Cristina García-Salguero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management
- (2015) Keith S. Kaye et al. PHARMACOTHERAPY
- A Review of Antibiotic Use in Pregnancy
- (2015) P. Brandon Bookstaver et al. PHARMACOTHERAPY
- In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
- (2014) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Allergies in Children and Adults: From Clinical Symptoms to Skin Testing Diagnosis
- (2014) Antonino Romano et al. Journal of Allergy and Clinical Immunology-In Practice
- Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update
- (2012) Jun-ichi Wachino et al. DRUG RESISTANCE UPDATES
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial Stewardship
- (2012) Mera Ababneh et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa
- (2011) Glenn A. Pankuch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects
- (2011) Robert T. Cass et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
- (2011) Fred C. Tenover et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antistaphylococcal Activity of ACHN-490 Tested Alone and in Combination with Other Agents by Time-Kill Assay
- (2010) G. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimizing Aminoglycoside Use
- (2010) William A. Craig CRITICAL CARE CLINICS
- Combating evolution with intelligent design: the neoglycoside ACHN-490
- (2010) Eliana S Armstrong et al. CURRENT OPINION IN MICROBIOLOGY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria
- (2009) P. D. Mauldin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Mediated 16S rRNA Methylases in Aminoglycoside-Resistant Enterobacteriaceae Isolates in Shanghai, China
- (2008) Q. Wu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now